Newstral
Patrizia Cavazzoni
- Rethinking Interchangeability, Top Cases, and Battling Misinformation at FDLI’s Annual Conferencejdsupra.com
- Center for Clinical Trial Innovation furthers FDA’s diversity goals, rare disease drug development - Pilot program offers opportunity for enhanced interaction with FDAjdsupra.com
- FDA and OHRP publish draft guidance on facilitating understanding in informed consentjdsupra.com
- FDA clinical trial diversity workshop reveals agency’s expectations for sponsorsjdsupra.com
- Over-the-Counter Narcan Becomes Available as Overdoses Soar in Ohioclevescene.com
- MAmerica’s first over-the-counter birth-control pill adds to a complicated array of options for women7 min readmarketwatch.com
- ‘Good for Sweden’ and other quotes of the weekDallas News
- US approves ‘Opill’, the first over-the-counter birth control pillSydney Morning Herald
- DFDA approves first over-the-counter anti-overdose Narcan spray - Wed, 29 Mar 2023 PSTDaily News
- NFDA approves first over-the-counter nasal spray for opioid OD reversalnypost.com
- BBiotech Stocks Fell on Fear of Less Flexible FDA. This Analyst Isn't Worried. 3 min readbarrons.com
- FDA stays the course on abortion pills, rejecting demands from the left and rightPOLITICO
- FDA has women’s drug on a hit listArkansas Online
- FDA pushes to remove pregnancy drug, company pushes backSeattle Times
- California COVID-19 hospitalizations climb as new variants drive increase in casessacbee.com
- Nevada pharmacists allowed to prescribe Pfizer’s COVID-19 pillreviewjournal.com
- Feds permit pharmacists to prescribe Paxlovid pills for COVID-19reviewjournal.com
- Pharmacists can prescribe Pfizer’s antiviral therapy paxlovid; COVID-19 ranks behind only heart disease, cancer as a cause of death: COVID-19 roundup for Friday July 8The Plain Dealer
- U.S. allows pharmacists to prescribe Pfizer’s COVID-19 pillstaradvertiser.com
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.